185 related articles for article (PubMed ID: 34474512)
21. Economic evaluations and randomized trials in spinal disorders: principles and methods.
Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
[TBL] [Abstract][Full Text] [Related]
22. [Economic evaluation of targeted cancer therapy].
Ikeda S
Gan To Kagaku Ryoho; 2013 Aug; 40(8):967-70. PubMed ID: 23986036
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.
Korczak D; Dietl M; Steinhauser G
GMS Health Technol Assess; 2011 Apr; 7():Doc02. PubMed ID: 21468290
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: protocol for an economic evaluation alongside the SITLESS three-armed pragmatic randomised controlled trial.
Deidda M; Coll-Planas L; Giné-Garriga M; Guerra-Balic M; Roqué I Figuls M; Tully MA; Caserotti P; Rothenbacher D; Salvà Casanovas A; Kee F; Blackburn NE; Wilson JJ; Skjødt M; Denkinger M; Wirth K; McIntosh E;
BMJ Open; 2018 Oct; 8(10):e022266. PubMed ID: 30327403
[TBL] [Abstract][Full Text] [Related]
25. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
Anopa Y; Conway DI
Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of economic evaluations of exercise and physiotherapy for patients treated for breast cancer.
Khan KA; Mazuquin B; Canaway A; Petrou S; Bruce J
Breast Cancer Res Treat; 2019 Jul; 176(1):37-52. PubMed ID: 30997624
[TBL] [Abstract][Full Text] [Related]
27. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
[TBL] [Abstract][Full Text] [Related]
28. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.
Rodgers M; Asaria M; Walker S; McMillan D; Lucock M; Harden M; Palmer S; Eastwood A
Health Technol Assess; 2012 May; 16(28):1-130. PubMed ID: 22642789
[TBL] [Abstract][Full Text] [Related]
29. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
[TBL] [Abstract][Full Text] [Related]
30. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
[TBL] [Abstract][Full Text] [Related]
31. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
[TBL] [Abstract][Full Text] [Related]
32. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
33. Over-, under- and misuse of pain treatment in Germany.
Dietl M; Korczak D
GMS Health Technol Assess; 2011 Apr; 7():Doc03. PubMed ID: 21522485
[TBL] [Abstract][Full Text] [Related]
34. Economic Evaluations in the Diagnosis and Management of Traumatic Brain Injury: A Systematic Review and Analysis of Quality.
Alali AS; Burton K; Fowler RA; Naimark DM; Scales DC; Mainprize TG; Nathens AB
Value Health; 2015 Jul; 18(5):721-34. PubMed ID: 26297101
[TBL] [Abstract][Full Text] [Related]
35. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
37. Management of frozen shoulder: a systematic review and cost-effectiveness analysis.
Maund E; Craig D; Suekarran S; Neilson A; Wright K; Brealey S; Dennis L; Goodchild L; Hanchard N; Rangan A; Richardson G; Robertson J; McDaid C
Health Technol Assess; 2012; 16(11):1-264. PubMed ID: 22405512
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic review.
Ruger JP; Emmons KM
Value Health; 2008; 11(2):180-90. PubMed ID: 17854435
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
